Jeffrey S. Weber, MD, PhD, Discusses Anti-IL-6 Agents in Treating COVID-19-Induced Pneumonia

The deputy director at NYU Langone ’s Perlmutter Cancer Center explained the importance of these agents and the development of clinical trials in this setting.

Source: CancerNetwork - April 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news